International Journal of Hematology

Title Publication Date Language Citations
Body iron metabolism and pathophysiology of iron overload2008/07/01English378
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)2015/11/07English252
COVID-19-associated coagulopathy and disseminated intravascular coagulation2020/11/07English237
Iron and infection2017/11/16English172
The biology of thrombopoietin and thrombopoietin receptor agonists2013/07/01English168
Pathophysiology of thrombotic thrombocytopenic purpura2010/01/01English159
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version2016/03/18English152
Hypoxia-inducible factors and their roles in energy metabolism2012/04/26English137
Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation2015/11/20English131
Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma2009/06/23English130
Reactive oxygen species and hematopoietic stem cell senescence2011/05/13English129
Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia2013/05/14English124
FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance2013/04/24English122
Modern iron replacement therapy: clinical and pathophysiological insights2017/12/01English116
Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton’s jelly explants of human umbilical cord2009/08/06English115
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study2015/11/25English106
Molecular pathogenesis of multiple myeloma: basic and clinical updates2013/02/28English101
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders2009/04/02English99
Effects of hypoxia and HIFs on cancer metabolism2012/04/27English91
Protein C anticoagulant and cytoprotective pathways2012/04/01English90
Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia2013/08/15English89
Complexity of bone marrow hematopoietic stem cell niche2017/05/22English84
Nasal NK/T-cell lymphoma: epidemiology and pathogenesis2008/02/08English84
Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages2008/03/29English83
Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload2008/06/27English81
Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies2012/10/31English81
Chronic myeloid leukemia in Asia2008/12/20English80
Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib2008/07/17English80
Changes of hematological and immunological parameters in COVID-19 patients2020/07/12English80
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry2013/05/01English78